All Stories

  1. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019
  2. Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek Experience
  3. Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease
  4. The Burden of Community-Acquired Pneumonia Requiring Admission to an ICU in the United States
  5. Community acquired pneumonia: a cost-of-illness analysis in Greece
  6. Difficult to treat microorganisms in patients aged over 80 years with community-acquired pneumonia: the prevalence of PES pathogens
  7. Advances in molecular diagnostic tests for pneumonia
  8. Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study
  9. New antibiotics for community acquired pneumonia
  10. Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
  11. non invasive diagnosis of nosocomial pneumonia
  12. lymphopenia predicts mortality in patients with ICU pneumonia
  13. Drugs that increase the risk of community-acquired pneumonia: a narrative review
  14. Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia
  15. Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia
  16. Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia
  17. The clinical management of lower respiratory tract infections
  18. Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study
  19. Tracheoesophageal fistula managed with tracheal stent through flexible bronchoscopy without fluoroscopy
  20. Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
  21. Ceftobiprole for the treatment of pneumonia: a European perspective
  22. ICS and risk of pneumonia
  23. Macrolide resistance and outcomes of patients with Streptococcus pneumoniae pneumonia.
  24. Severe community-acquired pneumonia: Severity and management
  25. C-Reactive Protein at Discharge, Diabetes Mellitus and ≥1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
  26. Pharmacotherapy for lower respiratory tract infections
  27. SEVERE CAP IN THE ICU
  28. NEW DRUGS FOR MRSA
  29. Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey
  30. CAP IN COPD PATIENTS
  31. PNEUMONIA RELATED TO MECHANICAL VENTILATION OR NOT
  32. VALIDATE THE GUIDELINES FOR HAP
  33. VALIDATION OF IDSA/ATS GUIDELINES FOR CAP
  34. Exclusive Diagnostic Contribution of the Histology Specimens Obtained by 19-Gauge Transbronchial Aspiration Needle in Suspected Malignant Intrathoracic Lymphadenopathy
  35. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire